ClinicalTrials.Veeva

Menu

Prospective Randomized Study Comparing Endothelial Cell Loss Using the Tan EndoGlide With Forceps for Insertion of the Donor Graft in DSAEK

University Health Network, Toronto logo

University Health Network, Toronto

Status

Unknown

Conditions

Endothelial Cell Loss With Different Insertion Devices

Treatments

Device: Forceps for delivery of the donor graft
Device: Use of the Tan Endoglide to insert the donor graft

Study type

Interventional

Funder types

Other

Identifiers

NCT01284101
REB-10-0632-B

Details and patient eligibility

About

The Tan EndoGlide device results in less endothelial cell trauma during insertion of the donor corneal graft indicated by reduced endothelial cell loss at 1 year follow-up compared to the Forceps.

Enrollment

42 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients presenting with corneal decompensation requiring DSAEK with or without cataract surgery for visual rehabilitation.
  • Clinical diagnosis include endothelial cell dysfunction secondary to Fuchs endothelial dystrophy, pseudophakic or aphakic bullous keratopathy, failed penetrating keratoplasty or DSAEK, iridocorneal endothelial syndrome or trauma.
  • Ability to understand the nature of the procedure and give full informed consent.
  • Patients who are able to comply with the standard DSAEK follow-up protocol at the Toronto Western Hospital.

Exclusion criteria

  • Patients with late stage corneal decompensation with stromal scarring unsuitable for DSAEK and therefore requiring penetrating keratoplasty.
  • Patients with complex anterior segment pathology precluding successful DSAEK procedure.
  • Patients not giving full informed consent to participate in the trial

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

42 participants in 2 patient groups

Forceps delivery of donor graft
Active Comparator group
Description:
Using the forceps to insert the donor graft.
Treatment:
Device: Forceps for delivery of the donor graft
Tan Endoglide for insertion of the donor graft
Experimental group
Description:
Use of the Tan Endoglide for insertion of the donor graft.
Treatment:
Device: Use of the Tan Endoglide to insert the donor graft

Trial contacts and locations

1

Loading...

Central trial contact

Allan R Slomovic, MA MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems